Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 2102100

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 2102100

Hemorrhoids Market Size, Share, and Growth Analysis, By Disease Type (Internal Hemorrhoids, External Hemorrhoids), By Treatment Type, By Route of Administration, By Distribution Channel, By End User, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Hemorrhoids Market size was valued at USD 5.54 Billion in 2024 and is poised to grow from USD 5.8 Billion in 2025 to USD 8.36 Billion by 2033, growing at a CAGR of 4.68% during the forecast period (2026-2033).

The global hemorrhoids market encompasses pharmaceuticals, medical devices, and over-the-counter solutions targeting piles, which affect approximately fifteen percent of adults worldwide. The chronic nature of hemorrhoidal disease and high recurrence rates underpin its significance, alongside a growing preference for minimally invasive treatments that reduce hospital stays. The expanding aging population drives market demand, as age-related vascular issues increase hemorrhoidal cases, leading to a surge in therapeutic options. This demographic shift promotes investments in innovative devices, such as cryo-ablation catheters known for mitigating postoperative pain. Furthermore, partnerships between manufacturers and gastroenterology clinics to create bundled care pathways offer comprehensive treatment options, enhancing revenue beyond drug sales. This convergence of aging populations, technological advancements, and integrated services presents substantial growth potential for both established and emerging players in the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemorrhoids market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemorrhoids Market Segments Analysis

Global hemorrhoids market is segmented by disease type, treatment type, route of administration, distribution channel, end user and region. Based on disease type, the market is segmented into Internal Hemorrhoids, External Hemorrhoids and Mixed Hemorrhoids. Based on treatment type, the market is segmented into Conservative Treatment (Dietary Fiber, Stool Softeners, Lifestyle Modification), Pharmacological Treatment, Minimally Invasive Procedures and Surgical Procedures. Based on route of administration, the market is segmented into Topical, Oral and Injectable. Based on distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Based on end user, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemorrhoids Market

The global hemorrhoids market is experiencing growth due to the increasing prevalence of the condition among adults, influenced by factors such as sedentary lifestyles, unhealthy dietary choices, and heightened awareness regarding gastrointestinal health. This surge in awareness has led more individuals to seek medical attention for their discomfort, thereby broadening the potential patient base for available treatments. As healthcare professionals adopt proactive approaches to diagnose hemorrhoidal issues, there is a growing demand for various pharmaceutical and procedural interventions. This trend encourages manufacturers to innovate and expand their product offerings, while healthcare providers increasingly allocate resources toward preventive screenings and treatment options, further fueling market growth.

Restraints in the Global Hemorrhoids Market

The global hemorrhoids market faces significant challenges due to limited awareness of early symptoms, which hampers prompt diagnosis. Many individuals experience discomfort but do not seek treatment, resulting in a reduced patient pool and diminished demand for available therapies. This situation is exacerbated by educational gaps across different demographic groups, leading to the underutilization of existing medical solutions and slowing market penetration. Furthermore, public health campaigns often fail to effectively target high-risk populations, leaving them unaware of preventive measures and the importance of early evaluation, ultimately hindering overall market growth and adoption of effective treatments.

Market Trends of the Global Hemorrhoids Market

The Global Hemorrhoids market is witnessing a significant trend towards the adoption of minimally invasive technologies, fundamentally altering treatment paradigms. Clinicians are increasingly opting for procedures that minimize postoperative discomfort and expedite recovery for patients. Innovations such as advanced rubber band ligation, laser coagulation systems, and radiofrequency ablation are becoming commonplace in outpatient settings, streamlining care without the need for hospitalization. This shift is motivated by a growing patient preference for quicker recovery times and healthcare providers' efforts to reduce procedural costs while ensuring high therapeutic outcomes and enhanced patient satisfaction, ultimately positioning minimally invasive approaches as the standard of care in managing hemorrhoids.

Product Code: SQMIG35I3372

Table of Contents

Introduction

  • Objectives of the Study
  • Market Definition & Scope

Research Methodology

  • Research Process
  • Secondary & Primary Data Methods
  • Market Size Estimation Methods

Executive Summary

  • Global Market Outlook
  • Key Market Highlights
  • Segmental Overview
  • Competition Overview

Market Dynamics & Outlook

  • Macro-Economic Indicators
  • Drivers & Opportunities
  • Restraints & Challenges
  • Supply Side Trends
  • Demand Side Trends
  • Porters Analysis & Impact
    • Competitive Rivalry
    • Threat of Substitute
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factors
  • Market Impacting Factors
  • Top Investment Pockets
  • Ecosystem Mapping
  • Market Attractiveness Index 2025
  • PESTEL Analysis
  • Regulatory Landscape

Global Hemorrhoids Market Size by Disease Type & CAGR (2026-2033)

  • Market Overview
  • Internal Hemorrhoids
  • External Hemorrhoids
  • Mixed Hemorrhoids

Global Hemorrhoids Market Size by Treatment Type & CAGR (2026-2033)

  • Market Overview
  • Conservative Treatment (Dietary Fiber, Stool Softeners, Lifestyle Modification)
  • Pharmacological Treatment
    • Topical Medications
    • Oral Medications
    • Others
  • Minimally Invasive Procedures
    • Rubber Band Ligation
    • Sclerotherapy
    • Infrared Coagulation
    • Others
  • Surgical Procedures
    • Hemorrhoidectomy
    • Stapled Hemorrhoidopexy
    • Doppler-Guided Hemorrhoidal Artery Ligation (DG-HAL)
    • Others

Global Hemorrhoids Market Size by Route of Administration & CAGR (2026-2033)

  • Market Overview
  • Topical
  • Oral
  • Injectable

Global Hemorrhoids Market Size by Distribution Channel & CAGR (2026-2033)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Hemorrhoids Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics
  • Home Care Settings

Global Hemorrhoids Market Size & CAGR (2026-2033)

  • North America (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
    • US
    • Canada
  • Europe (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Disease Type, Treatment Type, Route of Administration, Distribution Channel, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Pfizer Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson Services Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bayer AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi SA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teva Pharmaceutical Industries Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Viatris Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sandoz International GmbH
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lupin Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cipla Limited
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sun Pharmaceutical Industries Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Dr Reddys Laboratories Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical LLC
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ConMed Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca plc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!